News
Spinout
Biotech spinout Kynos Therapeutics acquired by Dr Falk Pharma
Biotechnology spinout Kynos Therapeutics has been acquired by clinical stage biopharmaceutical company Dr. Falk Pharma GmbH, which will develop Kynos’ KMO inflammation inhibitors for the treatment of acute pancreatitis.







